Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Neoplasms 3Breast Neoplasms 3Cognitive Dysfunction 2Stroke 1Smoking Cessation 1Smoking 1Pain 1Motor Activity 1Lymphoma, Follicular 1Hemianopsia 1Depression 1Cognition Disorders 1Cancer Pain 1Breast Cancer Survivors 1Brain Neoplasms 1Brain Injuries, Traumatic 1Bone Neoplasms 1Blindness, Cortical 1Anxiety Disorders 1

Interventions

Fulvestrant 125Trastuzumab 114Paclitaxel 113Letrozole 108pembrolizumab 79pertuzumab 75palbociclib 75Capecitabine 72Anastrozole 72Cyclophosphamide 70Carboplatin 67abemaciclib 64exemestane 63Tamoxifen 63ribociclib 60trastuzumab deruxtecan 57Surveys and Questionnaires 51Specimen Handling 50Radiotherapy 49Docetaxel 49Magnetic Resonance Spectroscopy 48Blood Specimen Collection 40olaparib 39Standard of Care 36Biopsy 33sacituzumab govitecan 31130-nm albumin-bound paclitaxel 31Doxorubicin 30Exercise 29eribulin 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Neoplasms × Transcranial Direct Current Stimulation × 1 year × Clear all
NCT07587957 2026-05-14

Exploring the Feasibility of an Exercise and Noninvasive Brain Stimulation Intervention in Breast Cancer Survivors

Florida Atlantic University

Phase NA Recruiting
40 enrolled
Breast

Breast Neoplasms, Motor Activity

NCT07083518 2025-07-24

Transcranial Direct Current Stimulation for Cancer-related Cognitive Impairment in Breast Cancer Survivors

Anhui Medical University

Phase NA Active not recruiting
60 enrolled
Breast

Breast Neoplasms, Cognitive Dysfunction

NCT06053775 2025-07-20

ONCODEP

University of Santiago de Compostela

Phase NA Active not recruiting
82 enrolled
Breast

Breast Neoplasms, Depression, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡